 Thomas Morrison
Concepts (535)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chikungunya virus | 39 | 2025 | 76 | 14.610 |
Why?
| | Chikungunya Fever | 35 | 2025 | 76 | 11.110 |
Why?
| | Alphavirus Infections | 29 | 2024 | 44 | 8.440 |
Why?
| | Ross River virus | 19 | 2024 | 23 | 4.690 |
Why?
| | Viral Envelope Proteins | 13 | 2025 | 81 | 3.660 |
Why?
| | Virus Replication | 28 | 2025 | 452 | 3.570 |
Why?
| | Alphavirus | 11 | 2024 | 20 | 2.790 |
Why?
| | Interferon Type I | 10 | 2024 | 139 | 2.280 |
Why?
| | Antiviral Agents | 12 | 2025 | 715 | 2.190 |
Why?
| | Antibodies, Viral | 16 | 2025 | 602 | 2.000 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 356 | 1.980 |
Why?
| | Viremia | 4 | 2025 | 131 | 1.860 |
Why?
| | Disease Models, Animal | 27 | 2025 | 4078 | 1.770 |
Why?
| | Antibodies, Neutralizing | 10 | 2025 | 267 | 1.690 |
Why?
| | Animals | 98 | 2025 | 35391 | 1.600 |
Why?
| | Mice | 58 | 2025 | 16961 | 1.500 |
Why?
| | Virulence Factors | 5 | 2018 | 157 | 1.480 |
Why?
| | Receptors, Immunologic | 3 | 2023 | 217 | 1.450 |
Why?
| | Lymph Nodes | 4 | 2024 | 472 | 1.420 |
Why?
| | Adaptive Immunity | 5 | 2020 | 161 | 1.280 |
Why?
| | Viral Proteins | 12 | 2019 | 327 | 1.230 |
Why?
| | Mice, Inbred C57BL | 29 | 2024 | 5455 | 1.200 |
Why?
| | Viral Load | 11 | 2021 | 449 | 1.180 |
Why?
| | Newcastle disease virus | 13 | 2001 | 17 | 1.160 |
Why?
| | Viruses | 4 | 2022 | 100 | 1.140 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 4 | 2021 | 4 | 1.120 |
Why?
| | Viral Nonstructural Proteins | 5 | 2025 | 58 | 1.120 |
Why?
| | Viral Vaccines | 4 | 2022 | 94 | 1.110 |
Why?
| | Phagocytes | 2 | 2025 | 97 | 1.100 |
Why?
| | Monocytes | 4 | 2024 | 553 | 1.060 |
Why?
| | Arthritis | 4 | 2020 | 90 | 1.040 |
Why?
| | Virulence | 11 | 2024 | 255 | 1.030 |
Why?
| | Arginase | 3 | 2015 | 32 | 1.010 |
Why?
| | Clodronic Acid | 1 | 2025 | 12 | 0.940 |
Why?
| | B-Lymphocytes | 4 | 2020 | 816 | 0.940 |
Why?
| | Immune Evasion | 1 | 2025 | 56 | 0.920 |
Why?
| | 3' Untranslated Regions | 2 | 2024 | 138 | 0.870 |
Why?
| | Joints | 4 | 2020 | 101 | 0.860 |
Why?
| | Liposomes | 1 | 2025 | 171 | 0.850 |
Why?
| | Immunity, Innate | 7 | 2022 | 805 | 0.850 |
Why?
| | Interferon Regulatory Factors | 2 | 2022 | 33 | 0.840 |
Why?
| | RNA, Viral | 14 | 2024 | 620 | 0.840 |
Why?
| | RNA Virus Infections | 3 | 2019 | 13 | 0.830 |
Why?
| | Kupffer Cells | 2 | 2021 | 50 | 0.830 |
Why?
| | CD8-Positive T-Lymphocytes | 6 | 2024 | 855 | 0.830 |
Why?
| | Virion | 3 | 2022 | 83 | 0.820 |
Why?
| | Cell Line | 21 | 2024 | 2784 | 0.810 |
Why?
| | Musculoskeletal Diseases | 2 | 2016 | 69 | 0.800 |
Why?
| | Dendritic Cells | 3 | 2024 | 481 | 0.790 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2021 | 399 | 0.770 |
Why?
| | Inflammation | 9 | 2023 | 2750 | 0.750 |
Why?
| | Mice, Knockout | 17 | 2022 | 2881 | 0.730 |
Why?
| | Macrophages | 6 | 2022 | 1488 | 0.730 |
Why?
| | Neutrophils | 2 | 2020 | 1210 | 0.710 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2020 | 97 | 0.700 |
Why?
| | Viral Fusion Proteins | 8 | 2001 | 18 | 0.700 |
Why?
| | RNA Viruses | 2 | 2019 | 34 | 0.690 |
Why?
| | Capsid Proteins | 3 | 2020 | 90 | 0.680 |
Why?
| | Myositis | 3 | 2012 | 51 | 0.680 |
Why?
| | NADPH Oxidase 2 | 1 | 2020 | 38 | 0.670 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.660 |
Why?
| | Complement System Proteins | 4 | 2023 | 318 | 0.660 |
Why?
| | Quinolones | 1 | 2021 | 127 | 0.650 |
Why?
| | Myeloid Cells | 4 | 2024 | 142 | 0.650 |
Why?
| | Herpesvirus 4, Human | 4 | 2004 | 156 | 0.640 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2020 | 171 | 0.640 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.610 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 10 | 0.610 |
Why?
| | Vero Cells | 11 | 2024 | 66 | 0.600 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2024 | 186 | 0.570 |
Why?
| | Trans-Activators | 4 | 2004 | 393 | 0.570 |
Why?
| | Osteoarthritis | 1 | 2020 | 168 | 0.570 |
Why?
| | Muscle, Skeletal | 9 | 2020 | 1613 | 0.570 |
Why?
| | Humans | 74 | 2025 | 129626 | 0.560 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2017 | 7 | 0.550 |
Why?
| | Chronic Disease | 4 | 2019 | 1720 | 0.530 |
Why?
| | Endothelial Cells | 5 | 2024 | 749 | 0.530 |
Why?
| | Mutation, Missense | 2 | 2019 | 318 | 0.520 |
Why?
| | Gene Deletion | 3 | 2018 | 382 | 0.520 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 342 | 0.510 |
Why?
| | Amino Acid Substitution | 3 | 2014 | 283 | 0.510 |
Why?
| | Disease Outbreaks | 4 | 2023 | 349 | 0.500 |
Why?
| | Zika Virus | 1 | 2017 | 118 | 0.490 |
Why?
| | Immunization | 4 | 2024 | 411 | 0.490 |
Why?
| | Epitopes | 3 | 2025 | 472 | 0.470 |
Why?
| | Zika Virus Infection | 1 | 2017 | 155 | 0.460 |
Why?
| | Complement Activation | 5 | 2018 | 384 | 0.450 |
Why?
| | Tyrosine | 3 | 2013 | 223 | 0.420 |
Why?
| | Arthralgia | 1 | 2013 | 49 | 0.410 |
Why?
| | Antigen Presentation | 2 | 2024 | 207 | 0.410 |
Why?
| | Membrane Fusion | 3 | 2001 | 38 | 0.410 |
Why?
| | Histidine | 1 | 2013 | 60 | 0.410 |
Why?
| | Immunity, Cellular | 1 | 2014 | 265 | 0.400 |
Why?
| | Immunoglobulin G | 5 | 2024 | 851 | 0.390 |
Why?
| | Antibodies, Monoclonal | 5 | 2024 | 1366 | 0.390 |
Why?
| | Signal Transduction | 11 | 2024 | 4931 | 0.380 |
Why?
| | Sindbis Virus | 4 | 2017 | 10 | 0.380 |
Why?
| | DNA-Binding Proteins | 3 | 2004 | 1445 | 0.380 |
Why?
| | Severe Acute Respiratory Syndrome | 4 | 2018 | 13 | 0.380 |
Why?
| | Tenosynovitis | 1 | 2010 | 11 | 0.360 |
Why?
| | Emergency Responders | 2 | 2021 | 35 | 0.350 |
Why?
| | Up-Regulation | 1 | 2012 | 840 | 0.320 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2128 | 0.310 |
Why?
| | HN Protein | 3 | 1993 | 5 | 0.310 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 67 | 0.310 |
Why?
| | Macrophage-1 Antigen | 1 | 2008 | 28 | 0.300 |
Why?
| | Virus Diseases | 1 | 2011 | 210 | 0.300 |
Why?
| | T-Lymphocytes | 2 | 2019 | 1936 | 0.300 |
Why?
| | Mutation | 7 | 2025 | 3717 | 0.300 |
Why?
| | Spike Glycoprotein, Coronavirus | 4 | 2022 | 109 | 0.290 |
Why?
| | Phenylalanine | 2 | 2022 | 65 | 0.290 |
Why?
| | Arboviruses | 1 | 2008 | 13 | 0.290 |
Why?
| | Cell Membrane | 4 | 2018 | 734 | 0.290 |
Why?
| | Arbovirus Infections | 1 | 2008 | 19 | 0.290 |
Why?
| | Complement C3 | 4 | 2018 | 209 | 0.280 |
Why?
| | Cricetinae | 6 | 2020 | 279 | 0.280 |
Why?
| | Amino Acids | 2 | 2025 | 487 | 0.280 |
Why?
| | Adoptive Transfer | 2 | 2020 | 218 | 0.280 |
Why?
| | Mutagenesis, Site-Directed | 7 | 2010 | 361 | 0.280 |
Why?
| | Adenoviridae | 2 | 2021 | 193 | 0.280 |
Why?
| | Fibroblasts | 2 | 2024 | 953 | 0.260 |
Why?
| | West Nile virus | 2 | 2016 | 38 | 0.250 |
Why?
| | Phosphoproteins | 3 | 2016 | 335 | 0.250 |
Why?
| | Lung | 6 | 2024 | 3938 | 0.240 |
Why?
| | Cysteine Proteases | 1 | 2025 | 5 | 0.240 |
Why?
| | Orthobunyavirus | 1 | 2025 | 2 | 0.240 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2025 | 50 | 0.240 |
Why?
| | Bunyaviridae Infections | 1 | 2025 | 8 | 0.240 |
Why?
| | Arthritis, Infectious | 1 | 2006 | 59 | 0.230 |
Why?
| | Molecular Probes | 1 | 2025 | 36 | 0.230 |
Why?
| | Cytokines | 5 | 2020 | 2021 | 0.230 |
Why?
| | Mice, Inbred BALB C | 4 | 2018 | 1250 | 0.230 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2024 | 24 | 0.230 |
Why?
| | Down-Regulation | 2 | 2004 | 636 | 0.230 |
Why?
| | Microscopic Polyangiitis | 1 | 2024 | 12 | 0.230 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2024 | 35 | 0.230 |
Why?
| | Macaca mulatta | 2 | 2023 | 151 | 0.230 |
Why?
| | Thiazoles | 1 | 2024 | 117 | 0.220 |
Why?
| | Uridine | 1 | 2024 | 29 | 0.220 |
Why?
| | Amides | 1 | 2024 | 91 | 0.220 |
Why?
| | Immunoassay | 2 | 2021 | 107 | 0.220 |
Why?
| | Genome, Viral | 4 | 2019 | 128 | 0.220 |
Why?
| | Peroxidase | 1 | 2024 | 175 | 0.220 |
Why?
| | Membrane Proteins | 2 | 2022 | 1125 | 0.220 |
Why?
| | Genetic Fitness | 1 | 2024 | 56 | 0.220 |
Why?
| | Sequence Deletion | 1 | 2024 | 179 | 0.210 |
Why?
| | NADPH Oxidases | 1 | 2024 | 108 | 0.210 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2023 | 33 | 0.210 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 161 | 0.210 |
Why?
| | Methionine | 1 | 2024 | 155 | 0.210 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1109 | 0.200 |
Why?
| | Ovalbumin | 2 | 2024 | 178 | 0.200 |
Why?
| | Antigens, Viral | 2 | 2021 | 179 | 0.200 |
Why?
| | Robotics | 1 | 2023 | 93 | 0.200 |
Why?
| | Killer Cells, Natural | 3 | 2019 | 426 | 0.200 |
Why?
| | Robotic Surgical Procedures | 1 | 2023 | 115 | 0.190 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1098 | 0.190 |
Why?
| | Salmonella | 1 | 2022 | 58 | 0.190 |
Why?
| | NF-kappa B | 2 | 2008 | 665 | 0.190 |
Why?
| | Transcriptional Activation | 2 | 2022 | 367 | 0.190 |
Why?
| | Protein Biosynthesis | 4 | 2019 | 410 | 0.190 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 125 | 0.180 |
Why?
| | Base Sequence | 9 | 2010 | 2147 | 0.180 |
Why?
| | Female | 20 | 2024 | 68734 | 0.180 |
Why?
| | Benzene Derivatives | 1 | 2021 | 9 | 0.180 |
Why?
| | Gynecology | 1 | 2023 | 174 | 0.180 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.180 |
Why?
| | Horses | 1 | 2021 | 107 | 0.180 |
Why?
| | Interferon-gamma | 3 | 2010 | 772 | 0.180 |
Why?
| | Convalescence | 1 | 2021 | 18 | 0.180 |
Why?
| | Oligosaccharides | 1 | 2001 | 57 | 0.180 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2004 | 431 | 0.180 |
Why?
| | Nucleic Acid Conformation | 1 | 2024 | 706 | 0.180 |
Why?
| | Cell Proliferation | 2 | 2018 | 2373 | 0.170 |
Why?
| | Specimen Handling | 1 | 2022 | 162 | 0.170 |
Why?
| | Protein Domains | 1 | 2022 | 256 | 0.170 |
Why?
| | Proteome | 1 | 2025 | 438 | 0.170 |
Why?
| | Oocytes | 2 | 2004 | 174 | 0.170 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 9 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2020 | 2708 | 0.170 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2001 | 95 | 0.170 |
Why?
| | Xenopus | 1 | 2000 | 85 | 0.170 |
Why?
| | Culicidae | 2 | 2013 | 31 | 0.170 |
Why?
| | Type C Phospholipases | 1 | 2000 | 72 | 0.170 |
Why?
| | Influenza, Human | 2 | 2020 | 601 | 0.170 |
Why?
| | Lectins, C-Type | 1 | 2020 | 71 | 0.170 |
Why?
| | Interferon Regulatory Factor-3 | 2 | 2017 | 17 | 0.170 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 26 | 0.160 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 323 | 0.160 |
Why?
| | Blood Donors | 1 | 2021 | 96 | 0.160 |
Why?
| | Glycoproteins | 2 | 2016 | 338 | 0.160 |
Why?
| | Encephalomyelitis, Venezuelan Equine | 1 | 2019 | 1 | 0.160 |
Why?
| | STAT1 Transcription Factor | 2 | 2010 | 69 | 0.160 |
Why?
| | Benzylamines | 1 | 2019 | 41 | 0.160 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 47 | 0.160 |
Why?
| | Transfection | 7 | 2014 | 915 | 0.160 |
Why?
| | Blotting, Western | 3 | 2015 | 1206 | 0.160 |
Why?
| | Molecular Sequence Data | 7 | 2010 | 2835 | 0.160 |
Why?
| | Primates | 2 | 2017 | 120 | 0.160 |
Why?
| | Laparoscopy | 1 | 2023 | 450 | 0.160 |
Why?
| | Homeodomain Proteins | 3 | 2014 | 494 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 274 | 0.150 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.150 |
Why?
| | Viral Tropism | 2 | 2019 | 29 | 0.150 |
Why?
| | Leishmania donovani | 1 | 2018 | 7 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 183 | 0.150 |
Why?
| | Venules | 1 | 2018 | 14 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1202 | 0.150 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 14 | 0.150 |
Why?
| | Progesterone | 1 | 2000 | 245 | 0.150 |
Why?
| | Endothelium, Lymphatic | 1 | 2018 | 12 | 0.150 |
Why?
| | Genes, Viral | 5 | 2006 | 82 | 0.150 |
Why?
| | Peptides | 1 | 2024 | 926 | 0.150 |
Why?
| | src-Family Kinases | 1 | 2019 | 95 | 0.150 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 5 | 0.150 |
Why?
| | Hindlimb | 2 | 2010 | 120 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 106 | 0.140 |
Why?
| | Structure-Activity Relationship | 4 | 2024 | 545 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2019 | 1058 | 0.140 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 15 | 0.140 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.140 |
Why?
| | Aedes | 2 | 2019 | 60 | 0.140 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 40 | 0.140 |
Why?
| | Methotrexate | 1 | 2019 | 249 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.140 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 65 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2022 | 1266 | 0.140 |
Why?
| | Gene Expression | 4 | 2015 | 1465 | 0.140 |
Why?
| | Polysaccharides | 1 | 2018 | 86 | 0.140 |
Why?
| | Lysine | 1 | 2019 | 286 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 4 | 2012 | 457 | 0.140 |
Why?
| | HeLa Cells | 5 | 2023 | 612 | 0.140 |
Why?
| | Mutant Proteins | 2 | 2014 | 100 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 387 | 0.130 |
Why?
| | Mannose-Binding Lectin | 2 | 2018 | 23 | 0.130 |
Why?
| | Toll-Like Receptors | 1 | 2017 | 179 | 0.130 |
Why?
| | Male | 13 | 2024 | 63670 | 0.130 |
Why?
| | Antirheumatic Agents | 1 | 2019 | 280 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 198 | 0.130 |
Why?
| | Bacterial Proteins | 1 | 2022 | 836 | 0.130 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2016 | 51 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 487 | 0.130 |
Why?
| | Cytoplasm | 2 | 2017 | 269 | 0.130 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 23 | 0.120 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 37 | 0.120 |
Why?
| | alpha-Synuclein | 1 | 2015 | 31 | 0.120 |
Why?
| | RNA Caps | 1 | 2015 | 33 | 0.120 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2014 | 21 | 0.120 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 50 | 0.120 |
Why?
| | Communicable Disease Control | 1 | 2015 | 75 | 0.120 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 39 | 0.110 |
Why?
| | Friend murine leukemia virus | 1 | 2015 | 29 | 0.110 |
Why?
| | Vaccination | 2 | 2021 | 1347 | 0.110 |
Why?
| | Cytidine Deaminase | 1 | 2015 | 57 | 0.110 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2015 | 135 | 0.110 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2014 | 20 | 0.110 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2014 | 26 | 0.110 |
Why?
| | Pentose Phosphate Pathway | 1 | 2014 | 51 | 0.110 |
Why?
| | Animal Structures | 1 | 2014 | 9 | 0.110 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2014 | 34 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2015 | 1159 | 0.110 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2012 | 90 | 0.110 |
Why?
| | Glycosaminoglycans | 1 | 2013 | 84 | 0.110 |
Why?
| | Pandemics | 3 | 2023 | 1491 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 887 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 155 | 0.100 |
Why?
| | Arthritis, Experimental | 1 | 2014 | 135 | 0.100 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 382 | 0.100 |
Why?
| | ELAV Proteins | 1 | 2012 | 14 | 0.100 |
Why?
| | Hospitalization | 1 | 2022 | 2057 | 0.100 |
Why?
| | Amino Acid Sequence | 6 | 1994 | 2057 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1035 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2016 | 745 | 0.100 |
Why?
| | Arthritis, Reactive | 1 | 2012 | 8 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 309 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 432 | 0.090 |
Why?
| | Mosquito Vectors | 2 | 2024 | 26 | 0.090 |
Why?
| | Synovial Fluid | 2 | 2012 | 66 | 0.090 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2011 | 7 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 398 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1914 | 0.090 |
Why?
| | Newcastle Disease | 1 | 1990 | 1 | 0.090 |
Why?
| | Avian Leukosis Virus | 1 | 1990 | 6 | 0.090 |
Why?
| | Time Factors | 3 | 2021 | 6555 | 0.090 |
Why?
| | Reassortant Viruses | 1 | 2010 | 7 | 0.090 |
Why?
| | Protective Agents | 1 | 2011 | 39 | 0.090 |
Why?
| | Estradiol | 1 | 2014 | 494 | 0.090 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 157 | 0.090 |
Why?
| | Cell Survival | 3 | 2021 | 1076 | 0.090 |
Why?
| | Transcription, Genetic | 3 | 2004 | 1418 | 0.090 |
Why?
| | Chickens | 1 | 1990 | 189 | 0.090 |
Why?
| | Drug Resistance, Viral | 2 | 2025 | 110 | 0.080 |
Why?
| | DNA, Viral | 5 | 1993 | 347 | 0.080 |
Why?
| | Receptors, Interferon | 1 | 2010 | 50 | 0.080 |
Why?
| | Immunotherapy | 1 | 2014 | 596 | 0.080 |
Why?
| | Genetic Vectors | 3 | 2021 | 314 | 0.080 |
Why?
| | COS Cells | 2 | 2001 | 186 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 14 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 146 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2009 | 32 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 86 | 0.080 |
Why?
| | Calgranulin B | 1 | 2008 | 9 | 0.080 |
Why?
| | Flavivirus Infections | 1 | 2008 | 9 | 0.070 |
Why?
| | Flavivirus | 1 | 2008 | 17 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 834 | 0.070 |
Why?
| | Cricetulus | 3 | 2014 | 108 | 0.070 |
Why?
| | RNA, Small Interfering | 3 | 2020 | 591 | 0.070 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 86 | 0.070 |
Why?
| | Histocytochemistry | 1 | 2007 | 81 | 0.070 |
Why?
| | Promoter Regions, Genetic | 2 | 2009 | 1207 | 0.070 |
Why?
| | Insect Vectors | 1 | 2006 | 27 | 0.070 |
Why?
| | Serum | 1 | 2007 | 58 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 4084 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2060 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2022 | 593 | 0.060 |
Why?
| | RNA Interference | 2 | 2020 | 450 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2014 | 813 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 247 | 0.060 |
Why?
| | Glycosylation | 2 | 2006 | 153 | 0.060 |
Why?
| | Semliki forest virus | 1 | 2024 | 2 | 0.060 |
Why?
| | Organ Specificity | 1 | 2006 | 296 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2025 | 68 | 0.060 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2004 | 53 | 0.060 |
Why?
| | Chick Embryo | 4 | 1992 | 130 | 0.060 |
Why?
| | Enzyme Inhibitors | 2 | 2016 | 827 | 0.060 |
Why?
| | Phosphorylation | 4 | 2012 | 1713 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2008 | 723 | 0.060 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2024 | 23 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 20 | 0.060 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2004 | 113 | 0.060 |
Why?
| | I-kappa B Proteins | 1 | 2004 | 79 | 0.060 |
Why?
| | Sulfones | 1 | 2025 | 108 | 0.060 |
Why?
| | Churg-Strauss Syndrome | 1 | 2024 | 25 | 0.060 |
Why?
| | Transcription Factor RelA | 1 | 2004 | 84 | 0.060 |
Why?
| | Plasmids | 3 | 1991 | 359 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 135 | 0.060 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2024 | 43 | 0.060 |
Why?
| | Glomerulonephritis | 1 | 2024 | 46 | 0.060 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 51 | 0.060 |
Why?
| | CHO Cells | 2 | 2014 | 154 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 57 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2019 | 698 | 0.050 |
Why?
| | Cell Line, Transformed | 1 | 2004 | 141 | 0.050 |
Why?
| | Brain | 1 | 2015 | 2673 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 2 | 2001 | 39 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 53 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2023 | 110 | 0.050 |
Why?
| | Cloning, Molecular | 3 | 2008 | 525 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 192 | 0.050 |
Why?
| | Binding Sites | 2 | 2021 | 1248 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2004 | 167 | 0.050 |
Why?
| | Bone and Bones | 1 | 2006 | 294 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2009 | 651 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 223 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 940 | 0.050 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2023 | 171 | 0.050 |
Why?
| | Keratinocytes | 1 | 2004 | 243 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 174 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2023 | 118 | 0.050 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 54 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2014 | 2133 | 0.050 |
Why?
| | Basal Ganglia Diseases | 1 | 2001 | 8 | 0.050 |
Why?
| | Survival Analysis | 2 | 2015 | 1269 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 876 | 0.050 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2001 | 24 | 0.050 |
Why?
| | Australia | 1 | 2022 | 243 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2004 | 584 | 0.050 |
Why?
| | Cross Protection | 1 | 2021 | 5 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 110 | 0.050 |
Why?
| | Cross Reactions | 1 | 2021 | 133 | 0.050 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2021 | 25 | 0.040 |
Why?
| | Microsomes, Liver | 1 | 2021 | 87 | 0.040 |
Why?
| | Half-Life | 1 | 2021 | 162 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4404 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 124 | 0.040 |
Why?
| | Immunity | 1 | 2001 | 138 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 109 | 0.040 |
Why?
| | Tyrphostins | 1 | 2000 | 17 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 2000 | 36 | 0.040 |
Why?
| | Giant Cells | 2 | 1998 | 23 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.040 |
Why?
| | Genetic Engineering | 1 | 2021 | 87 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2739 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 276 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2001 | 376 | 0.040 |
Why?
| | Metformin | 1 | 2004 | 318 | 0.040 |
Why?
| | Phosphoserine | 1 | 2000 | 34 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2020 | 40 | 0.040 |
Why?
| | Kinetics | 2 | 2013 | 1645 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3186 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2000 | 158 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2019 | 140 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 173 | 0.040 |
Why?
| | Cadherins | 1 | 2020 | 190 | 0.040 |
Why?
| | Protein Transport | 2 | 2012 | 429 | 0.040 |
Why?
| | Poly I-C | 1 | 2018 | 62 | 0.040 |
Why?
| | Interferon-beta | 2 | 2009 | 89 | 0.040 |
Why?
| | Trypsin | 1 | 1998 | 74 | 0.040 |
Why?
| | Autocrine Communication | 1 | 2018 | 43 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2018 | 33 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 481 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 44 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2019 | 139 | 0.040 |
Why?
| | Antigens, CD | 1 | 2020 | 487 | 0.040 |
Why?
| | Paracrine Communication | 1 | 2018 | 61 | 0.040 |
Why?
| | Spleen | 1 | 2019 | 509 | 0.040 |
Why?
| | Chemokines | 1 | 2018 | 226 | 0.030 |
Why?
| | Ischemia | 1 | 2020 | 406 | 0.030 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2016 | 10 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2019 | 361 | 0.030 |
Why?
| | Length of Stay | 1 | 2022 | 1122 | 0.030 |
Why?
| | Capsid | 1 | 2017 | 90 | 0.030 |
Why?
| | Biological Transport | 3 | 1992 | 404 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 327 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 37 | 0.030 |
Why?
| | Virus Assembly | 1 | 2017 | 76 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1843 | 0.030 |
Why?
| | Ouabain | 1 | 2016 | 18 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2542 | 0.030 |
Why?
| | Digoxin | 1 | 2016 | 28 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2020 | 402 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1647 | 0.030 |
Why?
| | Monensin | 2 | 1985 | 4 | 0.030 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 2 | 1985 | 4 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2014 | 1687 | 0.030 |
Why?
| | Granuloma | 1 | 2015 | 89 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2011 | 0.030 |
Why?
| | Apoptosis | 1 | 2004 | 2492 | 0.030 |
Why?
| | Viral Plaque Assay | 2 | 1992 | 29 | 0.030 |
Why?
| | International Cooperation | 1 | 2015 | 175 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 11 | 0.030 |
Why?
| | NADP | 1 | 2014 | 47 | 0.030 |
Why?
| | RNA Stability | 1 | 2015 | 103 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1005 | 0.030 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 1974 | 13 | 0.030 |
Why?
| | Reticulocytes | 1 | 1974 | 18 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2014 | 50 | 0.030 |
Why?
| | Virus Attachment | 1 | 2013 | 16 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 131 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1212 | 0.030 |
Why?
| | Heparitin Sulfate | 1 | 2013 | 42 | 0.030 |
Why?
| | Drug Implants | 1 | 2014 | 82 | 0.030 |
Why?
| | Virus Internalization | 1 | 2013 | 47 | 0.030 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2014 | 56 | 0.030 |
Why?
| | Precipitin Tests | 1 | 1993 | 98 | 0.030 |
Why?
| | Static Electricity | 1 | 2013 | 116 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 119 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3080 | 0.030 |
Why?
| | Hydrogen Bonding | 1 | 2013 | 149 | 0.030 |
Why?
| | Mice, SCID | 1 | 2014 | 350 | 0.030 |
Why?
| | Cell Fusion | 1 | 1993 | 51 | 0.030 |
Why?
| | Conserved Sequence | 1 | 1993 | 227 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 584 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 140 | 0.030 |
Why?
| | Endosomes | 1 | 2013 | 126 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2013 | 179 | 0.020 |
Why?
| | Global Health | 1 | 2015 | 328 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2014 | 217 | 0.020 |
Why?
| | Protein Binding | 2 | 2009 | 2124 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 167 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 314 | 0.020 |
Why?
| | Caspases | 1 | 2012 | 245 | 0.020 |
Why?
| | Viral Structural Proteins | 1 | 1991 | 12 | 0.020 |
Why?
| | Poultry | 1 | 1990 | 9 | 0.020 |
Why?
| | Complement C5a | 1 | 2011 | 70 | 0.020 |
Why?
| | Tritium | 2 | 1985 | 75 | 0.020 |
Why?
| | Orthomyxoviridae | 1 | 1991 | 40 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 67 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 327 | 0.020 |
Why?
| | DNA | 2 | 1988 | 1404 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 1990 | 126 | 0.020 |
Why?
| | Polyribosomes | 2 | 1984 | 22 | 0.020 |
Why?
| | Insulin | 1 | 2000 | 2326 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2010 | 297 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3394 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2009 | 38 | 0.020 |
Why?
| | Antibody Formation | 1 | 1990 | 291 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 31136 | 0.020 |
Why?
| | Receptors, CCR | 1 | 2008 | 8 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2009 | 84 | 0.020 |
Why?
| | Virus Cultivation | 1 | 2008 | 28 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 132 | 0.020 |
Why?
| | Glucose | 1 | 2014 | 1002 | 0.020 |
Why?
| | Metabolomics | 1 | 2014 | 653 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 305 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1491 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1833 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 494 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2009 | 143 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 949 | 0.020 |
Why?
| | Genes | 1 | 1988 | 227 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2008 | 38 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 419 | 0.020 |
Why?
| | Protein Conformation | 2 | 1992 | 863 | 0.020 |
Why?
| | Neurons | 1 | 2015 | 1494 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9786 | 0.020 |
Why?
| | DNA, Recombinant | 1 | 1986 | 46 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 1986 | 189 | 0.020 |
Why?
| | Mercaptoethanol | 1 | 1985 | 11 | 0.020 |
Why?
| | Rats | 1 | 2014 | 5483 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2006 | 117 | 0.020 |
Why?
| | Fucose | 1 | 1985 | 3 | 0.020 |
Why?
| | Disulfides | 1 | 1985 | 97 | 0.020 |
Why?
| | Immune System | 1 | 2006 | 175 | 0.010 |
Why?
| | Poly A | 1 | 1984 | 48 | 0.010 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 47 | 0.010 |
Why?
| | Xenopus laevis | 1 | 2004 | 98 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 53 | 0.010 |
Why?
| | Receptor, Insulin | 1 | 2004 | 99 | 0.010 |
Why?
| | Response Elements | 1 | 2004 | 90 | 0.010 |
Why?
| | Computational Biology | 1 | 2008 | 596 | 0.010 |
Why?
| | RNA | 1 | 2010 | 882 | 0.010 |
Why?
| | Models, Genetic | 1 | 2006 | 593 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 843 | 0.010 |
Why?
| | Adult | 2 | 2021 | 35599 | 0.010 |
Why?
| | Basal Ganglia | 1 | 2001 | 53 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1308 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2004 | 1221 | 0.010 |
Why?
| | Carcinoma, Krebs 2 | 1 | 1974 | 1 | 0.010 |
Why?
| | Electrophoresis, Paper | 1 | 1974 | 1 | 0.010 |
Why?
| | Chromatography, Paper | 1 | 1974 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1974 | 15 | 0.010 |
Why?
| | Hydroxyapatites | 1 | 1974 | 12 | 0.010 |
Why?
| | Chromatography | 1 | 1974 | 25 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
| | Triticum | 1 | 1974 | 11 | 0.010 |
Why?
| | Tissue Extracts | 1 | 1974 | 19 | 0.010 |
Why?
| | Peptide Biosynthesis | 1 | 1974 | 13 | 0.010 |
Why?
| | Cell-Free System | 1 | 1974 | 48 | 0.010 |
Why?
| | Autoradiography | 1 | 1974 | 73 | 0.010 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1974 | 42 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1992 | 63 | 0.010 |
Why?
| | Viral Matrix Proteins | 1 | 1992 | 29 | 0.010 |
Why?
| | Rabbits | 1 | 1974 | 779 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1992 | 332 | 0.010 |
Why?
|
|
Morrison's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|